Activity of gepotidacin against molecularly characterized β-lactamase-producing E. coli and K. pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2023)
Activity of gepotidacin against molecularly characterized β-lactamase-producing E. coli and K. pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2023). Lead author: Rodrigo E. Mendes, presented at ESCMID Global 2025, April 14, Vienna, Austria
Poster #P1217
